#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1225349	B	Activation of CD69 receptor in human lymphocytes expressing low number of receptors assessed as [3H]inositol bis-phosphate production at 60 uM after 4 mins by liquid scintillation counting	Homo sapiens	5		cell-based format	Scientific Literature
2.	ALA1225356	B	Activation of CD69 receptor in human lymphocytes expressing low number of receptors assessed as [3H]inositol tris-phosphate production at 60 uM after 2 mins by liquid scintillation counting	Homo sapiens	5		cell-based format	Scientific Literature
3.	ALA1225357	B	Activation of CD69 receptor in human lymphocytes expressing high number of receptors assessed as [3H]inositol bis-phosphate production at 60 uM after 4 mins by liquid scintillation counting	Homo sapiens	5		cell-based format	Scientific Literature
4.	ALA1225358	B	Activation of CD69 receptor in human lymphocytes expressing high number of receptors assessed as [3H]inositol tris-phosphate production at 60 uM after 2 mins by liquid scintillation counting	Homo sapiens	5		cell-based format	Scientific Literature
5.	ALA1225359	B	Activation of CD69 receptor in human lymphocytes expressing low number of receptors assessed as intracellular calcium release	Homo sapiens	5		cell-based format	Scientific Literature
6.	ALA1225360	B	Activation of CD69 receptor in human lymphocytes expressing low number of receptors assessed as intracellular calcium release in presence of ionomycin	Homo sapiens	6		cell-based format	Scientific Literature
7.	ALA1225361	B	Activation of CD69 receptor in human lymphocytes expressing high number of receptors assessed as intracellular calcium release	Homo sapiens	1		cell-based format	Scientific Literature
8.	ALA1225362	F	Cytotoxicity against human K562 cells by [51Cr] release test	Homo sapiens	2		cell-based format	Scientific Literature
9.	ALA1225363	F	Cytotoxicity against human Raji cells by [51Cr] release test	Homo sapiens	2		cell-based format	Scientific Literature
10.	ALA1225364	F	Antitumor activity against mouse B16-F1 cells implanted in C57BL/6 mouse assessed as tumor size at 1 umol administered every alternative day after 7 days of implantation measured on day 26 (Rvb = 0.6+/-0.2 cm2)	Mus musculus	4		cell-based format	Scientific Literature
11.	ALA1225365	F	Antitumor activity against mouse B16-F1 cells implanted in C57BL/6 mouse assessed as tumor size at 1 umol administered every alternative day after 7 days of implantation measured on day 30 (Rvb = 1.3+/-0.3 cm2)	Mus musculus	4		cell-based format	Scientific Literature
12.	ALA1225366	F	Cytotoxicity against mouse B16 cells at 1 umol by [51Cr] release test	Mus musculus	1		cell-based format	Scientific Literature
13.	ALA1225367	F	Cytotoxicity against mouse P815 cells at 1 umol by [51Cr] release test	Mus musculus	2		cell-based format	Scientific Literature
14.	ALA1225368	F	Cytotoxicity against mouse B16 cells at 0.1 umol by [51Cr] release test	Mus musculus	2		cell-based format	Scientific Literature
15.	ALA1225369	F	Cytotoxicity against mouse B16 cells at 0.01 umol by [51Cr] release test	Mus musculus	1		cell-based format	Scientific Literature